Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL
Open Access
- 22 April 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (4) , e1010206
Abstract
Reconstitution of the T cell repertoire after allogeneic stem cell transplantation is a long and often incomplete process. As a result, reactivation of Epstein-Barr virus (EBV) is a frequent complication that may be treated by adoptive transfer of donor-derived EBV-specific T cells. We generated donor-derived EBV-specific T cells by stimulation with peptides representing defined epitopes covering multiple HLA restrictions. T cells were adoptively transferred to a patient who had developed persisting high titers of EBV after allogeneic stem cell transplantation for angioimmunoblastic T-cell lymphoma (AITL). T cell receptor beta (TCRβ) deep sequencing showed that the T cell repertoire of the patient early after transplantation (day 60) was strongly reduced and only very low numbers of EBV-specific T cells were detectable. Manufacturing andin vitroexpansion of donor-derived EBV-specific T cells resulted in enrichment of EBV epitope-specific, HLA-restricted T cells. Monitoring of T cell clonotypes at a molecular level after adoptive transfer revealed that the dominant TCR sequences from peptide-stimulated T cells persisted long-term and established an EBV-specific TCR clonotype repertoire in the host, with many of the EBV-specific TCRs present in the donor. This reconstituted repertoire was associated with immunological control of EBV and with lack of further AITL relapse.Keywords
Funding Information
- Bundesministerium für Wirtschaft und Energie (ZIM fund KF 2766401FRO)
- Bayerisches Staatsministerium für Bildung und Kultus, Wissenschaft und Kunst (BayImmuNet Consortium)
- Deutsche Forschungsgemeinschaft (Project number 324392634 - TRR 221 and SFB643)
- Berlin School of Integrative Oncology
- Charité – Universitätsmedizin Berlin
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (Beca Conacyt)
- Wilhelm Sander-Stiftung (Project number 2018.135.1)
This publication has 80 references indexed in Scilit:
- Persistence of EBV Antigen-Specific CD8 T Cell Clonotypes during Homeostatic Immune Reconstitution in Cancer PatientsPLOS ONE, 2013
- Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantationNature Medicine, 2013
- Deep Sequencing of Antiviral T-Cell Responses to HCMV and EBV in Humans Reveals a Stable Repertoire That Is Maintained for Many YearsPLOS Pathogens, 2012
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipientsBlood, 2010
- Identification of Major Histocompatibility Complex Class II-Restricted Antigens and Epitopes of the Epstein-Barr Virus by a Novel Bacterial Expression Cloning ApproachJournal of Virology, 2006
- T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ productionInternational Immunology, 2006
- Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative diseaseBlood, 2003
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor.Journal of Cell Biology, 1991